Bringing the fundamentals into focus…
Back to Viemed Healthcare, Inc.
How Viemed Healthcare, Inc. stacks up
VMD · against 390 other Healthcare companies of similar size
Valuation
83/ 100
Near the top of its peers.
Ranked #69 of 391 · scores higher than 82% of peers
Bars: peers in each 10-point band of the valuation score28 peers with a valuation score of 80–89, including VMD · Click a bar to see the companies
Why valuation scores 83?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its EBITDA yield, free cash flow yield and earnings yield, which are stronger than most Healthcare peers.
- higher earnings for the price paid: stronger than 69% of peers. Earnings yield: 4.2% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 91% of peers. EBITDA yield: 14.9% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 91% of peers. Free cash flow yield: 8.1% vs peer median 0.0%
Metric by metric
Position: dot = VMD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 376 reported | 3.8% | -0.3% | 75% | 30% | |
| EBITDA yieldHigher is better · 394 reported | 15.4% | 2.2% | 88% | 50% | |
| Free cash flow yieldHigher is better · 188 reported | 8.1% | -9.2% | 93% | 20% | |
| Book yieldHigher is better · 385 reported | 40.0% | 50.1% | 41% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around VMDScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score